Linden Capital Partners
110 North Wacker DriveChicago, IL 60606
Website: lindenllc.com
Firm Size
- Assets Under Management (AUM):$7.9 Billion
- Number of Funds:19
- Employees:40
- Firm Type:Private Equity
- Focus Areas:
Services
Healthcare
Description
Linden Capital Partners is a private equity firm based in Chicago, Illinois. The company focuses on investing in middle-market healthcare and life sciences companies. With over 20 years of experience, Linden has a successful track record of partnering with companies in the healthcare sector to drive growth and create value. The firm primarily invests in companies involved in medical products, specialty distribution, pharmaceuticals, and healthcare services. Linden has a team of dedicated professionals with deep industry expertise and works closely with management teams to support their strategic initiatives. The firm's goal is to help companies achieve their full potential and deliver superior returns for its investors.Latest News
Powered by
May 28, 2024: Linden Announces Minority Investment from Blue Owl's GP Strategic Capital Platform and Lunate
Linden Capital Partners, a Chicago -based healthcare private equity firm, is pleased to announce a passive, minority investment from Blue Owl's GP Strategic Capital platform and Lunate Capital via their joint venture. Terms of the transaction were not disclosed.
Mar 12, 2024: Linden Capital Partners Acquires Alcresta Therapeutics, Inc.
Linden Capital Partners ("Linden"), a Chicago -based private equity firm focused exclusively on the healthcare industry, announced today the completion of its acquisition of Alcresta Therapeutics, Inc. ( "Alcresta"), a leader in commercializing novel enzyme-based products designed to address challenges faced by patients living with gastrointestinal disorders and rare diseases, from Athyrium Capital, Bessemer Venture Partners, Frazier Healthcare Partners, and HealthQuest Capital. HealthQuest Capital subsequently re-invested in Alcresta and will continue as a minority shareholder and board member.
Apr 04, 2023: TUSK Partners Advises Grinz Orthodontics in its sale to Smile Doctors
TUSK Partners ("TUSK"), the premier dental-focused M&A Advisor, advised Grinz Orthodontics in its sale to Smile Doctors , a portfolio company of Linden Capital Partners and Thomas H. Lee Partners . The transaction was led by Kevin Sauer , Director of Mergers & Acquisitions at TUSK Partners. Alex Cherniavsky , Taylor Adams , Sam Lupton , and George May spearheaded the diligence and analytics efforts for TUSK.